O
Oh2biotherapeutics
oh2biotherapeutics.com
Website unreachable since Oct 18, 2026
This company develops algorithms for generating therapeutic monoclonal antibodies, particularly targeting GPCRs. Their technology aims to simplify the antibody development process for researchers seeking new protein therapeutics.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops algorithms for generating therapeutic monoclonal antibodies, particularly targeting GPCRs. Their technology aims to simplify the antibody development process for researchers seeking new protein therapeutics.